Media Kit

The following documents are intended to provide an overview of the work we are doing at Lundbeck Inc. to address unmet medical needs and to introduce new treatment options.

Lundbeck Inc.

• About Us 

ATryn® (Antithrombin [Recombinant]) Media Kit

• Availability Press Release 
• Hereditary Antithrombin Deficiency Fact Sheet 
• ATryn Fact Sheet 
• Development Process Fact Sheet
• Full Prescribing Information

Sabril® (vigabatrin) Tablets & Oral Solution Media Kit

• FDA Approval Press Release
• NewsMarket B-Roll
• Refractory Complex Partial Seizures (CPS) Fact Sheet
• Infantile Spasms (IS) Fact Sheet
• Sabril Fact Sheet 
• Sabril Tablets Full Prescribing Information including Boxed Warning
• Sabril Oral Solution Full Prescribing Information including Boxed Warning
• Medication Guide  
• Sabril Oral Solution Dosing Guide   

Xenazine® (tetrabenazine) Media Kit

• Availability Press Release 
• Chorea Associated with Huntington's disease
• Huntington's Disease (HD)
• Xenazine Fact Sheet
• Full Prescribing Information including Boxed Warning
• Medication Guide